The U.S. Food and Drug Administration approved Abeona Therapeutics' gene therapy for a rare skin disorder on Tuesday. Shares ...

The U.S. Food and Drug Administration approved Abeona Therapeutics' gene therapy for a rare skin disorder on Tuesday. Shares of the Cleveland-based drugmaker rose 13% in premarket trading. The gene ...

Additional investors include global investment firm Viking Global Investors, charity foundation CureEB, the Epidermolysis ...

Krystal Biotech ( NASDAQ: KRYS) said that the European Commission granted marketing authorization to Vyjuvek for the treatment of wounds in certain patients with dystrophic epidermolysis bullosa, or ...

VYJUVEK approved for the treatment of DEB from birth in Europe Approval allows for dosing at home or in a healthcare setting, as well as patient or caregiver administration if deemed appropriate by a ...

The myasthenia gravis treatment market is anticipated to grow at a CAGR of 7.14% from US$1.973 billion in 2025 to US$2.785 ...

Vedder's work leveraging the fame and draw of his band's shows for curing epidermolysis bullosa (EB) has been turned into a ...